These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12574532)

  • 1. Ever decreasing circles: advances in antiplatelet therapy and anticoagulation.
    Kennedy J; Buchan AM
    Stroke; 2003 Feb; 34(2):348-50. PubMed ID: 12574532
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? No.
    Fisher M
    Stroke; 2009 May; 40(5):1944-5. PubMed ID: 19299634
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined aspirin plus warfarin: recent evidence and residual questions.
    Donnan GA; Davis SM
    Stroke; 2009 May; 40(5):1946. PubMed ID: 19299633
    [No Abstract]   [Full Text] [Related]  

  • 4. Long term anticoagulation or antiplatelet treatment. How do we decide between warfarin and aspirin?
    Cates C
    BMJ; 2001 Jul; 323(7306):235-6. PubMed ID: 11496890
    [No Abstract]   [Full Text] [Related]  

  • 5. Warfarin versus aspirin in the secondary prevention of stroke: the WARSS study.
    Redman AR; Allen LC
    Curr Atheroscler Rep; 2002 Jul; 4(4):319-25. PubMed ID: 12052284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?
    Hankey GJ
    Stroke; 2002 Jun; 33(6):1723-6. PubMed ID: 12053018
    [No Abstract]   [Full Text] [Related]  

  • 7. Review: anticoagulants may be better than antiplatelet agents for nonfatal stroke but not other vascular or fatal events in nonrheumatic AF.
    Ebrahim S; Taylor F
    ACP J Club; 2001; 135(2):A17. PubMed ID: 11571899
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral anticoagulants in patients with coronary artery disease.
    Anand SS; Yusuf S
    J Am Coll Cardiol; 2003 Feb; 41(4 Suppl S):62S-69S. PubMed ID: 12644343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term anticoagulation or antiplatelet treatment. Only warfarin has been shown to reduce stroke risk in patients with atrial fibrillation.
    Cleland JG; Kaye GC
    BMJ; 2001 Jul; 323(7306):233; author reply 235-6. PubMed ID: 11496885
    [No Abstract]   [Full Text] [Related]  

  • 11. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
    Furlan AJ
    Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635
    [No Abstract]   [Full Text] [Related]  

  • 13. What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Feb; 61(2):194-5. PubMed ID: 21375179
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.
    Smith DA
    Cardiology; 2008; 111(3):158-60. PubMed ID: 18434718
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
    Arjomand H; Cohen M; Ezekowitz MD
    J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation and anticoagulation.
    Maxim R
    Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139
    [No Abstract]   [Full Text] [Related]  

  • 17. Warfarin, aspirin, or both after myocardial infarction.
    Pullicino P; Thompson JL
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12529470
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Diner BM
    Ann Emerg Med; 2003 Jan; 41(1):141-3. PubMed ID: 12514695
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiplatelet versus anticoagulant therapies in advanced age: an unfinished task.
    García-Honrubia A; Roldán V; Climent V; Sogorb F; Marín F
    Int J Cardiol; 2006 Jun; 110(2):271-2. PubMed ID: 16343666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin bias in SPORTIF III trial.
    Vadivelu MK
    Lancet; 2004 Jun; 363(9426):2091; author reply 2091. PubMed ID: 15207972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.